Citadel Advisors’s Lumexa Imaging Holdings LMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.65M Sell
656,585
-193,415
-23% -$2.66M ﹤0.01% 4143
2025
Q4
$15.7M Buy
+850,000
New +$15.3M ﹤0.01% 2645

Other funds holding LMRI

Citadel Advisors's LMRI Position: Q1 2026 in Review

Citadel Advisors reduced its Lumexa Imaging Holdings (LMRI) stake by 23% in Q1 2026, selling an estimated $2.66M and leaving 656,585 shares worth $5.65M. The position accounts for ﹤0.01% of the portfolio, ranked #4143.

Citadel Advisors first reported a position in LMRI in Q4 2025 and has held it in 2 quarters since. The position peaked at $15.7M in Q4 2025. 90 funds tracked by Wall St. Rank hold LMRI as of Q1 2026.

  • Citadel Advisors held 656,585 shares of Lumexa Imaging Holdings worth $5.65M as of Q1 2026.
  • Citadel Advisors sold 193,415 Lumexa Imaging Holdings shares in Q1 2026, an estimated $2.66M.
  • Lumexa Imaging Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4143 holding.
  • Citadel Advisors first reported a position in Lumexa Imaging Holdings in Q4 2025 and has held it in 2 quarters since.
  • Citadel Advisors's Lumexa Imaging Holdings position peaked at $15.7M in Q4 2025.
  • 90 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.